Bristol-Myers Squibb Company has selected Laboratory Corporation of America Holdings (LabCorp) Clinical Trials for global central laboratory services and biomarker testing services for a period of five years.
Subscribe to our email newsletter
LabCorp chief medical officer Dr. Mark Brecher said, "We are excited to expand our relationship with Bristol-Myers Squibb to provide a more flexible and integrated approach to laboratory testing services in support of their innovative clinical development pipeline."
Earlier, Bristol-Myers’ early and late-stage clinical development programs were supported by LabCorp’s global central lab, biomarker and specialty testing capabilities.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.